FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385835461> ?p ?o ?g. }

• W4385835461 endingPage "12820" @default.
• W4385835461 startingPage "12820" @default.
• W4385835461 abstract "This study primarily aimed to investigate the combined effects of polydeoxyribonucleotide (PDRN) and extracorporeal shock wave therapy (ESWT) sequences on the regenerative processes in atrophied animal muscles. Thirty male New Zealand rabbits, aged 12 weeks, were divided into five groups: normal saline (Group 1), PDRN (Group 2), ESWT (Group 3), PDRN injection before ESWT (Group 4), and PDRN injection after ESWT (Group 5). After 2 weeks of cast immobilization, the respective treatments were administered to the atrophied calf muscles. Radial ESWT was performed twice weekly. Calf circumference, tibial nerve compound muscle action potential (CMAP), and gastrocnemius (GCM) muscle thickness after 2 weeks of treatment were evaluated. Histological and immunohistochemical staining, as well as Western blot analysis, were conducted 2 weeks post-treatment. Staining intensity and extent were assessed using semi-quantitative scores. Groups 4 and 5 demonstrated significantly greater calf muscle circumference, GCM muscle thickness, tibial nerve CMAP, and GCM muscle fiber cross-sectional area (type I, type II, and total) than the remaining three groups (p < 0.05), while they did not differ significantly in these parameters. Groups 2 and 3 showed higher values for all the mentioned parameters than Group 1 (p < 0.05). Group 4 had the greatest ratio of vascular endothelial growth factor (VEGF) to platelet endothelial cell adhesion molecule-1 (PECAM-1) in the GCM muscle fibers compared to the other four groups (p < 0.05). Western blot analysis revealed significantly higher expression of angiogenesis cytokines in Groups 4 and 5 than in the other groups (p < 0.05). The combination of ESWT and PDRN injection demonstrated superior regenerative efficacy for atrophied calf muscle tissue in rabbit models compared to these techniques alone or saline. In particular, administering ESWT after PDRN injection yielded the most favorable outcomes in specific parameters." @default.
• W4385835461 created "2023-08-16" @default.
• W4385835461 creator A5022162451 @default.
• W4385835461 creator A5027327441 @default.
• W4385835461 creator A5061403152 @default.
• W4385835461 creator A5064268947 @default.
• W4385835461 creator A5075121035 @default.
• W4385835461 date "2023-08-15" @default.
• W4385835461 modified "2023-10-18" @default.
• W4385835461 title "Polydeoxyribonucleotide and Shock Wave Therapy Sequence Efficacy in Regenerating Immobilized Rabbit Calf Muscles" @default.
• W4385835461 cites W1508560063 @default.
• W4385835461 cites W1540738611 @default.
• W4385835461 cites W1962538984 @default.
• W4385835461 cites W1974529719 @default.
• W4385835461 cites W1976609510 @default.
• W4385835461 cites W1984454036 @default.
• W4385835461 cites W1992817995 @default.
• W4385835461 cites W2012714656 @default.
• W4385835461 cites W2015127751 @default.
• W4385835461 cites W2015613680 @default.
• W4385835461 cites W2017235030 @default.
• W4385835461 cites W2017567167 @default.
• W4385835461 cites W2019760454 @default.
• W4385835461 cites W2021813349 @default.
• W4385835461 cites W2025600381 @default.
• W4385835461 cites W2032501755 @default.
• W4385835461 cites W2048099971 @default.
• W4385835461 cites W2052885628 @default.
• W4385835461 cites W2059665474 @default.
• W4385835461 cites W2062709166 @default.
• W4385835461 cites W2073665284 @default.
• W4385835461 cites W2094344379 @default.
• W4385835461 cites W2109062406 @default.
• W4385835461 cites W2116574880 @default.
• W4385835461 cites W2129717757 @default.
• W4385835461 cites W2158851615 @default.
• W4385835461 cites W2168847336 @default.
• W4385835461 cites W2170183238 @default.
• W4385835461 cites W2176295824 @default.
• W4385835461 cites W2183455362 @default.
• W4385835461 cites W2246071658 @default.
• W4385835461 cites W2283066545 @default.
• W4385835461 cites W2300338173 @default.
• W4385835461 cites W2468224059 @default.
• W4385835461 cites W2531051312 @default.
• W4385835461 cites W2602864067 @default.
• W4385835461 cites W2766986571 @default.
• W4385835461 cites W2793326913 @default.
• W4385835461 cites W2796823556 @default.
• W4385835461 cites W2804523516 @default.
• W4385835461 cites W2837506775 @default.
• W4385835461 cites W2943965210 @default.
• W4385835461 cites W2973345677 @default.
• W4385835461 cites W3117201170 @default.
• W4385835461 cites W3134797538 @default.
• W4385835461 cites W3161881058 @default.
• W4385835461 cites W4200529941 @default.
• W4385835461 doi "https://doi.org/10.3390/ijms241612820" @default.
• W4385835461 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37629001" @default.
• W4385835461 hasPublicationYear "2023" @default.
• W4385835461 type Work @default.
• W4385835461 citedByCount "0" @default.
• W4385835461 crossrefType "journal-article" @default.
• W4385835461 hasAuthorship W4385835461A5022162451 @default.
• W4385835461 hasAuthorship W4385835461A5027327441 @default.
• W4385835461 hasAuthorship W4385835461A5061403152 @default.
• W4385835461 hasAuthorship W4385835461A5064268947 @default.
• W4385835461 hasAuthorship W4385835461A5075121035 @default.
• W4385835461 hasBestOaLocation W43858354611 @default.
• W4385835461 hasConcept C104317684 @default.
• W4385835461 hasConcept C105702510 @default.
• W4385835461 hasConcept C126322002 @default.
• W4385835461 hasConcept C126894567 @default.
• W4385835461 hasConcept C134018914 @default.
• W4385835461 hasConcept C141071460 @default.
• W4385835461 hasConcept C16685009 @default.
• W4385835461 hasConcept C185592680 @default.
• W4385835461 hasConcept C204232928 @default.
• W4385835461 hasConcept C2776415932 @default.
• W4385835461 hasConcept C2777397205 @default.
• W4385835461 hasConcept C2780394083 @default.
• W4385835461 hasConcept C55493867 @default.
• W4385835461 hasConcept C71924100 @default.
• W4385835461 hasConceptScore W4385835461C104317684 @default.
• W4385835461 hasConceptScore W4385835461C105702510 @default.
• W4385835461 hasConceptScore W4385835461C126322002 @default.
• W4385835461 hasConceptScore W4385835461C126894567 @default.
• W4385835461 hasConceptScore W4385835461C134018914 @default.
• W4385835461 hasConceptScore W4385835461C141071460 @default.
• W4385835461 hasConceptScore W4385835461C16685009 @default.
• W4385835461 hasConceptScore W4385835461C185592680 @default.
• W4385835461 hasConceptScore W4385835461C204232928 @default.
• W4385835461 hasConceptScore W4385835461C2776415932 @default.
• W4385835461 hasConceptScore W4385835461C2777397205 @default.
• W4385835461 hasConceptScore W4385835461C2780394083 @default.
• W4385835461 hasConceptScore W4385835461C55493867 @default.
• W4385835461 hasConceptScore W4385835461C71924100 @default.
• W4385835461 hasIssue "16" @default.

• next